Cargando…
Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi
BACKGROUND: Lymphatic filariasis (LF) and human immunodeficiency virus (HIV) are major public health problems. Individuals may be co-infected, raising the possibility of important interactions between these two pathogens with consequences for LF elimination through annual mass drug administration (M...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456405/ https://www.ncbi.nlm.nih.gov/pubmed/26042839 http://dx.doi.org/10.1371/journal.pntd.0003825 |
_version_ | 1782374835502972928 |
---|---|
author | Tafatatha, Terence Taegtmeyer, Miriam Ngwira, Bagrey Phiri, Amos Kondowe, Mariot Piston, Wilson Molesworth, Anna Kayuni, Ndoliwe Koole, Olivier Crampin, Amelia Horton, John French, Neil |
author_facet | Tafatatha, Terence Taegtmeyer, Miriam Ngwira, Bagrey Phiri, Amos Kondowe, Mariot Piston, Wilson Molesworth, Anna Kayuni, Ndoliwe Koole, Olivier Crampin, Amelia Horton, John French, Neil |
author_sort | Tafatatha, Terence |
collection | PubMed |
description | BACKGROUND: Lymphatic filariasis (LF) and human immunodeficiency virus (HIV) are major public health problems. Individuals may be co-infected, raising the possibility of important interactions between these two pathogens with consequences for LF elimination through annual mass drug administration (MDA). METHODOLOGY AND PRINCIPAL FINDINGS: We analysed circulating filarial antigenaemia (CFA) by HIV infection status among adults in two sites in northern Malawi, a region endemic for both LF and HIV. Stored blood samples and data from two geographically separate studies were used: one a recruitment phase of a clinical trial of anti-filarial agent dosing regimens, and the other a whole population annual HIV sero-survey. In study one, 1,851 consecutive adult volunteers were screened for HIV and LF infection. CFA prevalence was 25.4% (43/169) in HIV-positive and 23.6% (351/1487) in HIV-negative participants (p=0.57). Geometric mean CFA concentrations were 859 and 1660 antigen units per ml of blood (Ag/ml) respectively, geometric mean ratio (GMR) 0.85, 95%CI 0.49-1.50. In 7,863 adults in study two, CFA prevalence was 20.9% (86/411) in HIV-positive and 24.0% (1789/7452) in HIV–negative participants (p=0.15). Geometric mean CFA concentrations were 630 and 839 Ag/ml respectively (GMR 0.75, 95%CI 0.60-0.94). In the HIV-positive group, antiretroviral therapy (ART) use was associated with a lower CFA prevalence, 12.7% (18/142) vs. 25.3% (67/265), (OR 0.43, 95%CI 0.24-0.76). Prevalence of CFA decreased with duration of ART use, 15.2% 0-1 year (n=59), 13.6% >1-2 years (n=44), 10.0% >2-3 years (n=30) and 0% >3-4 years treatment (n=9), p<0.01 χ(2) for linear trend. CONCLUSIONS/SIGNIFICANCE: In this large cross-sectional study of two distinct LF-exposed populations, there is no evidence that HIV infection has an impact on LF epidemiology that will interfere with LF control measures. A significant association of ART use with lower CFA prevalence merits further investigation to understand this apparent beneficial impact of ART. |
format | Online Article Text |
id | pubmed-4456405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-44564052015-06-09 Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi Tafatatha, Terence Taegtmeyer, Miriam Ngwira, Bagrey Phiri, Amos Kondowe, Mariot Piston, Wilson Molesworth, Anna Kayuni, Ndoliwe Koole, Olivier Crampin, Amelia Horton, John French, Neil PLoS Negl Trop Dis Research Article BACKGROUND: Lymphatic filariasis (LF) and human immunodeficiency virus (HIV) are major public health problems. Individuals may be co-infected, raising the possibility of important interactions between these two pathogens with consequences for LF elimination through annual mass drug administration (MDA). METHODOLOGY AND PRINCIPAL FINDINGS: We analysed circulating filarial antigenaemia (CFA) by HIV infection status among adults in two sites in northern Malawi, a region endemic for both LF and HIV. Stored blood samples and data from two geographically separate studies were used: one a recruitment phase of a clinical trial of anti-filarial agent dosing regimens, and the other a whole population annual HIV sero-survey. In study one, 1,851 consecutive adult volunteers were screened for HIV and LF infection. CFA prevalence was 25.4% (43/169) in HIV-positive and 23.6% (351/1487) in HIV-negative participants (p=0.57). Geometric mean CFA concentrations were 859 and 1660 antigen units per ml of blood (Ag/ml) respectively, geometric mean ratio (GMR) 0.85, 95%CI 0.49-1.50. In 7,863 adults in study two, CFA prevalence was 20.9% (86/411) in HIV-positive and 24.0% (1789/7452) in HIV–negative participants (p=0.15). Geometric mean CFA concentrations were 630 and 839 Ag/ml respectively (GMR 0.75, 95%CI 0.60-0.94). In the HIV-positive group, antiretroviral therapy (ART) use was associated with a lower CFA prevalence, 12.7% (18/142) vs. 25.3% (67/265), (OR 0.43, 95%CI 0.24-0.76). Prevalence of CFA decreased with duration of ART use, 15.2% 0-1 year (n=59), 13.6% >1-2 years (n=44), 10.0% >2-3 years (n=30) and 0% >3-4 years treatment (n=9), p<0.01 χ(2) for linear trend. CONCLUSIONS/SIGNIFICANCE: In this large cross-sectional study of two distinct LF-exposed populations, there is no evidence that HIV infection has an impact on LF epidemiology that will interfere with LF control measures. A significant association of ART use with lower CFA prevalence merits further investigation to understand this apparent beneficial impact of ART. Public Library of Science 2015-06-04 /pmc/articles/PMC4456405/ /pubmed/26042839 http://dx.doi.org/10.1371/journal.pntd.0003825 Text en © 2015 Tafatatha et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Tafatatha, Terence Taegtmeyer, Miriam Ngwira, Bagrey Phiri, Amos Kondowe, Mariot Piston, Wilson Molesworth, Anna Kayuni, Ndoliwe Koole, Olivier Crampin, Amelia Horton, John French, Neil Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi |
title | Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi |
title_full | Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi |
title_fullStr | Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi |
title_full_unstemmed | Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi |
title_short | Human Immunodeficiency Virus, Antiretroviral Therapy and Markers of Lymphatic Filariasis Infection: A Cross-sectional Study in Rural Northern Malawi |
title_sort | human immunodeficiency virus, antiretroviral therapy and markers of lymphatic filariasis infection: a cross-sectional study in rural northern malawi |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456405/ https://www.ncbi.nlm.nih.gov/pubmed/26042839 http://dx.doi.org/10.1371/journal.pntd.0003825 |
work_keys_str_mv | AT tafatathaterence humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT taegtmeyermiriam humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT ngwirabagrey humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT phiriamos humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT kondowemariot humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT pistonwilson humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT molesworthanna humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT kayunindoliwe humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT kooleolivier humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT crampinamelia humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT hortonjohn humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi AT frenchneil humanimmunodeficiencyvirusantiretroviraltherapyandmarkersoflymphaticfilariasisinfectionacrosssectionalstudyinruralnorthernmalawi |